These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 9713447)

  • 41. Fractional exhaled nitric oxide as a predictor of response to inhaled corticosteroids in patients with non-specific respiratory symptoms and insignificant bronchodilator reversibility: a randomised controlled trial.
    Price DB; Buhl R; Chan A; Freeman D; Gardener E; Godley C; Gruffydd-Jones K; McGarvey L; Ohta K; Ryan D; Syk J; Tan NC; Tan T; Thomas M; Yang S; Konduru PR; Ngantcha M; d'Alcontres MS; Lapperre TS
    Lancet Respir Med; 2018 Jan; 6(1):29-39. PubMed ID: 29108938
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhaled salmeterol: a review of its efficacy in chronic obstructive pulmonary disease.
    Jarvis B; Markham A
    Drugs Aging; 2001; 18(6):441-72. PubMed ID: 11419918
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Montelukast vs. inhaled low-dose budesonide as monotherapy in the treatment of mild persistent asthma: a randomized double blind controlled trial.
    Kumar V; Ramesh P; Lodha R; Pandey RM; Kabra SK
    J Trop Pediatr; 2007 Oct; 53(5):325-30. PubMed ID: 17623754
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease.
    Broseghini C; Testi R; Polese G; Tosatto R; Rossi A
    Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Once-daily budesonide via Turbuhaler improves symptoms in adults with persistent asthma.
    Banov CH; Howland WC; Lumry WR
    Ann Allergy Asthma Immunol; 2001 Jun; 86(6):627-32. PubMed ID: 11428734
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Immediate antiinflammatory effects of inhaled budesonide in patients with asthma.
    Mendes ES; Rebolledo P; Campos M; Wanner A
    Ann Am Thorac Soc; 2014 Jun; 11(5):706-11. PubMed ID: 24735128
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of inhaled salmeterol in the management of smokers with chronic obstructive pulmonary disease: a single centre randomised, double blind, placebo controlled, crossover study.
    Ulrik CS
    Thorax; 1995 Jul; 50(7):750-4. PubMed ID: 7570409
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of inhaled corticosteroids on the development of emphysema in smokers assessed by annual computed tomography.
    Shaker SB; Dirksen A; Ulrik CS; Hestad M; Stavngaard T; Laursen LC; Maltbaek N; Clementsen P; Skjaerbaek N; Nielsen L; Stoel B; Skovgaard LT; Tonnesen P
    COPD; 2009 Apr; 6(2):104-11. PubMed ID: 19378223
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy and safety of RPL554, a dual PDE3 and PDE4 inhibitor, in healthy volunteers and in patients with asthma or chronic obstructive pulmonary disease: findings from four clinical trials.
    Franciosi LG; Diamant Z; Banner KH; Zuiker R; Morelli N; Kamerling IM; de Kam ML; Burggraaf J; Cohen AF; Cazzola M; Calzetta L; Singh D; Spina D; Walker MJ; Page CP
    Lancet Respir Med; 2013 Nov; 1(9):714-27. PubMed ID: 24429275
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inhaled steroid therapy in chronic obstructive pulmonary disease.
    Whittaker AJ; Spiro SG
    Curr Opin Pulm Med; 2000 Mar; 6(2):104-9. PubMed ID: 10741768
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Should inhaled corticosteroids be used in the long term treatment of chronic obstructive pulmonary disease?
    Burge S
    Drugs; 2001; 61(11):1535-44. PubMed ID: 11577791
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peak flow variation in childhood asthma: correlation with symptoms, airways obstruction, and hyperresponsiveness during long-term treatment with inhaled corticosteroids. Dutch CNSLD Study Group.
    Brand PL; Duiverman EJ; Waalkens HJ; van Essen-Zandvliet EE; Kerrebijn KF
    Thorax; 1999 Feb; 54(2):103-7. PubMed ID: 10325912
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients.
    Ozol D; Aysan T; Solak ZA; Mogulkoc N; Veral A; Sebik F
    Respir Med; 2005 Dec; 99(12):1494-500. PubMed ID: 15946834
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Controlled trial of inhaled budesonide in patients with cystic fibrosis and chronic bronchopulmonary Psuedomonas aeruginosa infection.
    Bisgaard H; Pedersen SS; Nielsen KG; Skov M; Laursen EM; Kronborg G; Reimert CM; Høiby N; Koch C
    Am J Respir Crit Care Med; 1997 Oct; 156(4 Pt 1):1190-6. PubMed ID: 9351621
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Response to corticosteroids in chronic airflow obstruction: relationship to emphysema and airways collapse.
    Weir DC; Gove RI; Robertson AS; Burge PS
    Eur Respir J; 1991 Nov; 4(10):1185-90. PubMed ID: 1804665
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dose-dependent onset and cessation of action of inhaled budesonide on exhaled nitric oxide and symptoms in mild asthma.
    Kharitonov SA; Donnelly LE; Montuschi P; Corradi M; Collins JV; Barnes PJ
    Thorax; 2002 Oct; 57(10):889-96. PubMed ID: 12324677
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Changes in symptoms, peak expiratory flow, and sputum flora during treatment with antibiotics of exacerbations in patients with chronic obstructive pulmonary disease in general practice.
    Sachs AP; Koëter GH; Groenier KH; van der Waaij D; Schiphuis J; Meyboom-de Jong B
    Thorax; 1995 Jul; 50(7):758-63. PubMed ID: 7570411
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic Corticosteroids in Chronic Obstructive Pulmonary Disease Exacerbations (SCCOPE): rationale and design of an equivalence trial. Veterans Administration Cooperative Trials SCCOPE Study Group.
    Erbland ML; Deupree RH; Niewoehner DE
    Control Clin Trials; 1998 Aug; 19(4):404-17. PubMed ID: 9683314
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Time course of response to oral and inhaled corticosteroids in non-asthmatic chronic airflow obstruction.
    Weir DC; Robertson AS; Gove RI; Burge PS
    Thorax; 1990 Feb; 45(2):118-21. PubMed ID: 2180106
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.